|
| Date |
The Brigham And Women s Hospital Inc patents (updated weekly) - BOOKMARK this page |
| 08/17/17 |  Elastic biopolymer and use as a tissue adhesive |
| 08/10/17 | Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 08/10/17 | Compositions and methods for epithelial stem cell expansion and culture |
| 08/10/17 | Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases |
| 08/03/17 | Compounds and methods for modulating vascular injury |
| 07/27/17 | Fc receptor (fcrn) binding peptides and uses thereof |
| 07/27/17 | Biopolymer-nanoparticle composite implant for tumor cell tracking |
| 07/20/17 | Small molecule inhibitors of usp1 deubiquitinating enzyme activity |
| 07/20/17 | Methods and compositions relating to treatment of pulmonary arterial hypertension |
|
| 07/06/17 | Diagnostic and therapeutic uses of gelsolin in renal failure |
| 07/06/17 | Free-breathing non-contrast mr angiography |
| 06/29/17 | Detectors, detecting ionizing radiation using high energy current |
| 06/22/17 | Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells |
| 06/15/17 | Methods and compositions for the generation and maintenance of regulatory t cells |
| 06/08/17 | Platelet additive solution having a beta-galactosidase inhibitor |
|
| 06/08/17 | Tissue transplant compositions and methods for use |
| 06/08/17 | Selective differentiation, identification, and modulation of human th17 cells |
| 05/18/17 | Self-assembled residence devices and related methods |
| 05/11/17 | Stem cell derived factors for treating pathologic conditions |
| 05/11/17 | Enteric elastomers |
| 05/04/17 | Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy |
| 05/04/17 | Circulating kim-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney |
| 04/27/17 | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| 04/20/17 | Metabolically-activated drug conjugates to overcome resistance in cancer therapy |
| 04/20/17 | Residence structures and related methods |
| 04/20/17 | Pyrimidine compounds and methods using the same |
| 04/20/17 | Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring |
| 04/20/17 | Diagnosis and treatment of invasive aspergillosis |
| 04/13/17 | Stabilized assembled nanostructures for delivery of encapsulated agents |
| 04/13/17 | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 04/06/17 | Methods for diagnosing and assessing risk of developing glomerulosclerosis |
| 03/30/17 | Identification of compounds that disperse tdp-43 inclusions |
| 03/16/17 | Positioning apparatus |
| 03/16/17 | Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss |
| 03/02/17 | Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathways |
| 02/23/17 | Targeting parp1 for treatment of tsc and cancers |
| 02/23/17 | Polymeric materials for bio-applications |
| 02/16/17 | Targeted nanoparticle compositions and methods of their use to treat obesity |
| 02/16/17 | Methods to manipulate alpha-fetoprotein (afp) |
| 02/16/17 | Compositions and methods for treating subjects with immune-mediated diseases |
|
| 02/09/17 | Drug delivery composition comprising a self-assembled gelator |
| 02/09/17 | Methods for the treatment of kidney fibrosis |
| 02/09/17 | Methods for predicting anti-cancer response |
| 02/02/17 | Herpes simplex virus vaccines |
| 02/02/17 | Classification of myc-driven b-cell lymphomas |
| 01/19/17 | Medical support device |
| 01/19/17 | Targeted therapeutics |
| 01/19/17 | Anti-fibulin-3 antibodies and uses thereof |
| 01/12/17 | Nsd3 inhibitors for treatment of cancers |
| 01/05/17 | Fiducial markers, systems, and methods of registration |
| 01/05/17 | Nanostructured gels capable of controlled release of entrapped agents |
| 01/05/17 | Receptor-targeted nanoparticles for enhanced transcytosis mediated drug delivery |
| 01/05/17 | Compositions and methods for modulating an immune response |
| 12/29/16 | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 12/29/16 | T cell balance gene expression, compositions of matters and methods of use thereof |
| 12/22/16 | Compositions and methods for sensitizing a neoplastic cell to radiation |
| 12/22/16 | Nanoscale platinum compounds and methods of use thereof |
| 12/08/16 | Endothelial cell genes and uses thereof |
| 11/24/16 | Microvessel endothelial cell surface markers and uses thereof |
| 11/24/16 | Knock-in rodent comprising a mutation in an endogenous crbn locus and methods of use thereof |
| 11/24/16 | Cationic materials and formulations for drug delivery |
| 11/24/16 | Uses of gli1 in detecting tissue fibrosis |
| 11/17/16 | Targeted delivery of immunoregulatory drugs |
| 11/17/16 | Molecular signatures of conditions associated with longevity |
| 11/03/16 | Substituted urea eif2alpha kinase activators |
|
| 11/03/16 | Compositions and methods for culturing cells from normal human tubo-ovarian epithelium and human tubo-ovarian tumors |
| 11/03/16 | Recurrent gene fusions in prostate cancer |
| 11/03/16 | Detection of an antibody against a pathogen |
| 10/27/16 | Docosahexaenoyl ethanolamides |
| 10/27/16 | Treating neurodegenerative disease |
| 10/13/16 | Therapies for left ventricular non-compaction and dilated cardiomyopathy |
| 10/13/16 | Impedance matching for ultrasound phased array elements |
| 10/06/16 | Compositions and methods for treating pulmonary hypertension |
| 10/06/16 | Parp9 and parp14 as key regulators of macrophage activation |
| 10/06/16 | System and studying matrix vesicle calcification |
| 09/29/16 | Natural igm antibodies and inhibitors thereof |
| 09/29/16 | Compositions and methods for selecting a treatment for b-cell neoplasias |
| 09/22/16 | Treatment of cancer |
| 09/22/16 | Methods of generating intermediate mesoderm cells from human pluripotent stem cells |
| 09/22/16 | Targeting microrna-26a/b for the treatment of neurodegenerative disease |
|
| 09/15/16 | Growth differentiation factor (gdf) for treatment of diastolic heart failure |
| 09/15/16 | Relevance of achieved levels of markers of systemic inflammation following treatment |
| 09/08/16 | Methods for treating or preventing acute vascular leak |
| 08/25/16 | Cationic nanoparticles for co-delivery of nucleic acids and therapeutic agents |
| 08/25/16 | Multipotent stem cells and uses thereof |
| 08/18/16 | Allele-specific rna silencing for the treatment of hypertrophic cardiomyopathy |
| 08/11/16 | Use of gelsolin to diagnose and treat inflammatory diseases |
| 08/11/16 | Compositions and methods of prophylaxis for contact dermatitis |
| 08/11/16 | Particles with multiple functionalized surface domains |
| 08/04/16 | Methods and compositions for increasing neurogenesis and angiogenesis |
| 07/28/16 | Methods for modulating immune responses during chronic immune conditions by targeting metallothioneins |
| 07/14/16 | Treatment of synucleinopathies |
| 07/07/16 | Compositions and methods for epithelial stem cell expansion and culture |
| 06/30/16 | Methods to improve cell therapy |
| 06/30/16 | System for screening particles |
| 06/23/16 | Platelet additive solution having a beta-galactosidase inhibitor |
| 06/16/16 | Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions |
| 06/09/16 | Methods and systems for determining m. tuberculosis infection |
| 06/09/16 | Sensitive diagnostic assay for inclusion body mysitis |
| 05/26/16 | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
|
| 05/26/16 | Nanocomposite hydrogels |
| 05/19/16 | Targeting abcb5 for cancer therapy |
| 05/12/16 | Treatment of mtor hyperactive related diseases and disorders |
| 05/12/16 | Notch inhibition in the treatment and prevention of obesity |
| 05/05/16 | Thymic regeneration |
| 05/05/16 | Fc receptor (fcrn) binding peptides and uses thereof |
| 05/05/16 | Cancer diagnosis, treatment selection and treatment |
| 04/28/16 | Bmp inhibitors and methods of use thereof |
| 04/28/16 | Methods for treating congestive heart failure |
| 04/28/16 | Diagnosing and monitoring cns malignancies using microrna |
 |
| 04/21/16 | Wound healing and tissue engineering |
| 04/14/16 | Heterocyclic inhibitors of necroptosis |
| 04/07/16 | Bet inhibition therapy for heart disease |
| 04/07/16 | Recurrent gene fusions in prostate cancer |
| 03/17/16 | Needle positioning apparatus |
| 03/10/16 | Methods for treating immune diseases |
| 03/03/16 | Methods and compositions of treating autoimmune diseases |
| 03/03/16 | Treatment of synucleinopathies |
| 02/25/16 | Methods for treatment of cardiomyopathy |
| 02/18/16 | Bmp inhibitors and methods of use thereof |
|
| 01/28/16 | Treatment of lymphangioleiomyomatosis |
| 01/28/16 | Compounds to modulate intestinal absorption of nutrients |
| 01/28/16 | Targeted polymeric inflammation-resolving nanoparticles |
| 01/28/16 | Small molecule inhibitors of ebola and lassa fever viruses and methods of use |
| 01/28/16 | Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 01/28/16 | Use of urinary protein biomarkers to distinguish between neoplastic and non-neoplastic disease of the prostate |
| 01/21/16 | Vibro-based delivery system and immune suppression |
| 01/14/16 | Nanoparticle-based compositions |
| 01/14/16 | Combinatorial compositions and methods for treatment of melanoma |
| 01/14/16 | Therapeutic and diagnostic methods relating to cancer stem cells |
| 01/14/16 | Detection of organ rejection |
| 01/07/16 | Platelet storage and reduced bacterial proliferation in platelet products using a sialidase inhibitor |
| 01/07/16 | Notch inhibition in the prevention of vein graft failure |
| 01/07/16 | Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions |
| 12/31/15 | Mechanical structure of articulated sheath |
| 12/31/15 | Methods and compositions relating to the treatment of cancer |
| 12/17/15 | T cell balance gene expression, compositions of matters and methods of use thereof |
| 12/10/15 | Using galectin-binding carbohydrates as predictors of melanoma progression and metastasis |
| 12/03/15 | Methods for cardioprotection and cardioregeneration with dimers of egf family ligands |
| 12/03/15 | Metabolic imaging methods for assessment of oocytes and embryos |
| 11/26/15 | Swellable adhesive needles |
| 11/26/15 | Phosphatidylcholine transfer protein inhibitors |
| 11/26/15 | Tetracycline-regulated gene expression in hsv-1 vectors |
| 11/26/15 | Compositions and methods for diagnosing and assessing inflammatory myopathies |
| 11/26/15 | Treatment and prognosis of lymphangioleiomyomatosis |
| 11/19/15 | Treatment of mtor hyperactive related diseases and disorders |
| 11/19/15 | Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 11/19/15 | Peptides useful for modulating histone demethylase function |
| 11/19/15 | Method and system for diagnosing and treating preeclampsia |
| 11/12/15 | Methods to diagnose and treat mullerian adenosarcoma |
|
| 11/05/15 | A inhibiting calcification of a macrophage-derived matrix vesicle |
| 10/29/15 | Metabolic profiling in tissue and serum is indicative of tumor differentiation in prostate cancer |
| 10/22/15 | Methods and assays relating to macrophage differentiation |
| 10/22/15 | Tissue sample preparation, and maldi ms imaging thereof |
| 10/22/15 | Method for diagnosing and treating kidney injury or disease |
| 10/15/15 | Sortilin 1 is a novel inducer of vascular calcification |
| 10/15/15 | Diagnosis and treatment of endometriosis and related conditions |
| 10/08/15 | Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathways |
| 10/08/15 | Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
| 10/08/15 | System and detecting cancer |
| 10/01/15 | Enhancement of the immune response |
| 09/24/15 | Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use |
| 09/24/15 | Detection and treatment of non-dermal fibrosis |
| 09/17/15 | Tissue transplant compositions and methods for use |
| 09/10/15 | Glycosphingolipids and methods of use thereof |
| 08/27/15 | Placement apparatus |
| 08/27/15 | Hsf1 and hsf1 cancer signature set genes and uses relating thereto |
| 08/13/15 | Modulation of the immune response |
| 07/30/15 | Methods and devices for inserting a needle |
| 07/30/15 | Compounds and methods for treating mammalian gastrointestinal microbial infections |
|
| 07/30/15 | Functional assay for cancer recurrence and malignant potential |
| 07/23/15 | Modulation of the immune response |
| 07/23/15 | Compounds and methods for modulating pharmacokinetics |
| 07/23/15 | Compositions and methods for treating hypertension |
| 07/23/15 | Methods of diagnosing infectious disease pathogens and their drug sensitivity |
| 07/09/15 | Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
| 07/02/15 | Mass production and size control of nanoparticles through controlled microvortices |
| 07/02/15 | Targeted therapeutics |
| 06/25/15 | Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy |
| 06/25/15 | Compositions for treating cancer and methods for making the same |
| 06/25/15 | Methods for treatment of cardiovascular disease |
| 06/18/15 | Polysaccharide compositions and methods of use |
| 06/18/15 | Selective cartilage therapy |
| 06/11/15 | Polymers for functional particles |
| 06/04/15 | 1l1rl-1 as a cardiovascular disease marker and therapeutic target |
| 05/07/15 | Bone and metal targeted polymeric nanoparticles |
| 04/30/15 | Beta-cell replication promoting compounds and methods of their use |
| 04/30/15 | 14-hydroxy-docosahexaenoic acid compounds |
| 04/30/15 | 14-hydroxy-docosahexaenoic acid compounds |
| 04/30/15 | 14-hydroxy-docosahexaenoic acid compounds |
|
| 04/30/15 | In vitro culture conditions for t-cell acute lymphoblastic leukemia/lymphoma |
| 04/23/15 | Generating pluripotent cells de novo |
| 04/23/15 | Methods and devices for sensing tissues and tissue compartments |
| 04/09/15 | Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 03/26/15 | Control apparatus and tendon-driven device |
| 03/19/15 | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 03/05/15 | Neutralizing antibody for epstein barr virus-associated disease |
| 03/05/15 | Methods of modulating immunity |
| 02/26/15 | Compositions and methods for sensitizing a neoplastic cell to radiation |
| 02/19/15 | Selective differentiation, identification, and modulation of human th17 cells |
| 02/12/15 | Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/15 | Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/15 | Growth differentiation factor (gdf) for treatment of diastolic heart failure |
| 02/05/15 | Methods for predicting anti-cancer response |
| 01/29/15 | Treatment of uterine leiomyomata |
| 01/22/15 | System for targeted delivery of therapeutic agents |
| 01/22/15 | Docosahexaenoyl ethanolamides |
| 01/22/15 | Right ventricular papillary approximation |
| 01/08/15 | Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 12/25/14 | Treatment of uterine leiomyomata |
| 12/18/14 | Detecting inclusion body myositis |
| 11/06/14 | Anti-ceacam1 recombinant antibodies for cancer therapy |
| 10/30/14 | Methods of treating cardiovascular and metabolic diseases |
| 10/23/14 | Herpes simplex virus vaccines |
| 10/09/14 | Targeting abcb5 for cancer therapy |
| 10/09/14 | Methods of treating acute kidney injury with retinoic acid |
| 10/02/14 | Method for treatment of mesothelioma |
| 10/02/14 | Stem cell derived factors for treating pathologic conditions |
| 10/02/14 | Diagnosis and treatment of mesothelioma |
| 08/28/14 | Lipid-containing psa compositions, methods of isolation and methods of use thereof |
|
| 08/28/14 | Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 08/21/14 | Micrornas in neurodegenerative disorders |
| 07/24/14 | Treatment of cancer |
| 07/17/14 | Structural mutations in titin cause dilated cardiomyopathy |
| 07/10/14 | Diagnosing, monitoring and treating inflammation |
| 07/03/14 | Methods and compositions for the treatment of cancer |
| 06/26/14 | Methods of treating inflammatory diseases by targeting the chemoattractant cytokine receptor 2 (ccr2) or chemokine (c-c motif) ligand 2 (ccl2) |
| 06/26/14 | Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma |
| 06/19/14 | Multipotent stem cells and uses thereof |
| 06/19/14 | Galectin-immunoglobulin chimeric molecules |
| 06/12/14 | Kruppel-like factor 10 (klf10) as a biomarker of endothelial progenitor cell dysfunction |
| 06/05/14 | Systems and methods for portable magnetic resonance measurements of lung properties |
| 05/15/14 | Biologic replacement for fibrin clot |
| 05/15/14 | Treatment of acetaminophen-induced liver damage by the administration of modulators of nitric oxide |
| 05/08/14 | Adjuvant incorporation in immunonanotherapeutics |
| 05/01/14 | Methods of using microrna-26a to promote angiogenesis |
| 04/10/14 | Zwitterionic immunomodulators for the teatment of asthma and allergy |
| 03/20/14 | Anti-inflammatory particles |
| 03/20/14 | Microvascular anastomotic coupler and methods of using same |
| 03/06/14 | Protein biomarkers for the diagnosis of prostate cancer |
| 02/06/14 | Targeting of antigen presenting cells with immunonanotherapeutics |
| 01/23/14 | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 01/23/14 | Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
| 12/26/13 | Diagnosing and monitoring cns malignancies using microrna |
| 12/19/13 | Multipotent stem cells and uses thereof |
| 12/19/13 | Notch inhibition in the treatment of cardiovascular disease |
| 12/19/13 | Modulation of the immune response |
| 12/12/13 | Assays and methods to sequence microbes directly from immune complexes |
| 12/05/13 | Fibrinogen and kidney damage |
